NeuroXT
NeuroXT, a South Korean company, develops advanced AI software platforms for brain disease treatment. Their products enable biomarker-based diagnosis and therapeutic suitability assessment from a single MRI scan. Key products include NEXT-ATN, NEXT-ALZ-CDx, and NEXT-S, which leverage deep neural network AI technology to support precision medicine in neurology. The company positions itself as a solution partner providing optimal digital technology solutions for brain disease drug development, aiming to lead precision and build standards in the field.
NeuroXT
NeuroXT, a South Korean company, develops advanced AI software platforms for brain disease treatment. Their products enable biomarker-based diagnosis and therapeutic suitability assessment from a single MRI scan. Key products include NEXT-ATN, NEXT-ALZ-CDx, and NEXT-S, which leverage deep neural network AI technology to support precision medicine in neurology. The company positions itself as a solution partner providing optimal digital technology solutions for brain disease drug development, aiming to lead precision and build standards in the field.